Source - RNS
RNS Number : 7260X
UDG Healthcare Public Limited Co.
01 May 2019


 1 May 2019

UDG Healthcare plc

Notice of Interim Results


UDG Healthcare plc ("the Group"), a leading international healthcare services provider, will issue its interim results for the half year ended 31 March 2019 at 07:00am (BST) on Tuesday 21 May 2019.

Brendan McAtamney, Chief Executive Officer, and Nigel Clerkin, Chief Financial Officer, will be hosting a presentation for analysts and investors at the London Stock Exchange at 08:30am (BST) to discuss the company's half year results and provide an update on each of the Group's divisions.

Analysts and investors wishing to attend are asked to contact Powerscourt on the details below, as all attendees need to be pre-registered. The presentation will also be available via live audio webcast and conference call, the details of which are below.  


Audio webcast:


Conference call dial-in details:


+44 (0) 20 7192 8000


+353 (0) 1 431 9615

United States of America

+1 631 510 7495

Participant Code



For further information, please contact:

UDG Healthcare plc

Keith Byrne


Head of Investor Relations, Strategy & Corporate Communications


Tel: +353-1-468-9000






Lisa Kavanagh / Jana Tsiligiannis / Ella Morris


Tel: +44-207-250-1446

[email protected]





About UDG Healthcare plc:

UDG Healthcare plc (LON: UDG) is a leading international partner of choice delivering advisory, communication, commercial, clinical and packaging services to the healthcare industry, employing over 8,500 people with operations in 26 countries and delivering services in over 50 countries.

UDG Healthcare plc operates across two divisions: Ashfield and Sharp.

Ashfield is a global leader in advisory, communication, commercial and clinical services for the pharmaceutical and healthcare industries. It focuses on supporting healthcare professionals and patients at all stages of the product life cycle. The division provides field and contact centre sales teams, healthcare communications, patient support, audit, advisory, medical information and event management services to over 300 healthcare companies.

Sharp is a global leader in contract commercial packaging and clinical trial packaging services for the pharmaceutical and healthcare industries, operating from state-of the-art facilities in the US and Europe.

The company is listed on the London Stock Exchange and is a constituent of the FTSE 250. For more information, please go to:






This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit